KR100881089B1 - The manufacturing method of herbal chokong (pickled soybean) pill - Google Patents
The manufacturing method of herbal chokong (pickled soybean) pill Download PDFInfo
- Publication number
- KR100881089B1 KR100881089B1 KR1020070121462A KR20070121462A KR100881089B1 KR 100881089 B1 KR100881089 B1 KR 100881089B1 KR 1020070121462 A KR1020070121462 A KR 1020070121462A KR 20070121462 A KR20070121462 A KR 20070121462A KR 100881089 B1 KR100881089 B1 KR 100881089B1
- Authority
- KR
- South Korea
- Prior art keywords
- vinegar
- herbal
- soybean
- extract
- beans
- Prior art date
Links
- 239000006187 pill Substances 0.000 title claims abstract description 28
- 235000010469 Glycine max Nutrition 0.000 title claims description 97
- 244000068988 Glycine max Species 0.000 title claims description 94
- 238000004519 manufacturing process Methods 0.000 title claims description 30
- 239000000052 vinegar Substances 0.000 claims abstract description 59
- 235000021419 vinegar Nutrition 0.000 claims abstract description 57
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 37
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 37
- 241000411851 herbal medicine Species 0.000 claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 30
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 18
- 239000011575 calcium Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 17
- 210000003278 egg shell Anatomy 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 3
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 59
- 238000005554 pickling Methods 0.000 claims description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 12
- 229940010454 licorice Drugs 0.000 claims description 12
- 241001061264 Astragalus Species 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 11
- 235000006533 astragalus Nutrition 0.000 claims description 11
- 210000004233 talus Anatomy 0.000 claims description 11
- 241000209020 Cornus Species 0.000 claims description 10
- 235000008216 herbs Nutrition 0.000 claims description 6
- 238000004898 kneading Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- YSXLJTGZMRNQSG-UHFFFAOYSA-L disodium;6-amino-5-[[2-[4-[2-[4-[2-[(2-amino-5-sulfonatonaphthalen-1-yl)diazenyl]phenyl]sulfonyloxyphenyl]propan-2-yl]phenoxy]sulfonylphenyl]diazenyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].C1=CC=C2C(N=NC3=CC=CC=C3S(=O)(=O)OC3=CC=C(C=C3)C(C)(C=3C=CC(OS(=O)(=O)C=4C(=CC=CC=4)N=NC=4C5=CC=CC(=C5C=CC=4N)S([O-])(=O)=O)=CC=3)C)=C(N)C=CC2=C1S([O-])(=O)=O YSXLJTGZMRNQSG-UHFFFAOYSA-L 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 30
- 235000005911 diet Nutrition 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 20
- 230000037213 diet Effects 0.000 abstract description 17
- 235000019640 taste Nutrition 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 4
- 238000002791 soaking Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 49
- 230000001093 anti-cancer Effects 0.000 description 43
- 239000000469 ethanolic extract Substances 0.000 description 24
- 239000000047 product Substances 0.000 description 16
- 230000003078 antioxidant effect Effects 0.000 description 15
- 235000009200 high fat diet Nutrition 0.000 description 15
- 206010006187 Breast cancer Diseases 0.000 description 11
- 208000026310 Breast neoplasm Diseases 0.000 description 11
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 11
- 201000005202 lung cancer Diseases 0.000 description 11
- 208000020816 lung neoplasm Diseases 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229940045109 genistein Drugs 0.000 description 6
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 6
- 235000006539 genistein Nutrition 0.000 description 6
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000001789 adipocyte Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 235000021329 brown rice Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 210000001596 intra-abdominal fat Anatomy 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000007683 Pediatric Obesity Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical group [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 235000021095 non-nutrients Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 한방 초콩환의 제조방법에 관한 것으로, 더욱 상세하게는 항암 성능, 항산화 성능, 다이어트 효과 등을 가지며 일반인들이 복용하기에 적절한 맛을 가지는 한방 초콩환의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing herbal herbal soybean pill, and more particularly, to a method of producing herbal herbal soybean pill having anticancer performance, antioxidant performance, dietary effect, etc., and having a taste suitable for the general public.
우리나라는 2000년 서울시민 가운데 32.7%(남자 33.1%, 여자 32.2%)가 비만체형으로 분류되었으며, 한국 성인의 비만 비율이 해마다 3%씩 증가하고 있다고 발표되었다. WHO에 따르면 한국 소아비만은 10년 동안 2배 이상 증가했으며, 비만의 정도가 심한 ‘중등도 비만’이 대폭 증가하고 있음을 보고하였다. 미국사회는 만연한 아동비만 문제로 새로운 영양프로그램의 필요성을 제기하고 있으며 아동의 비만 문제를 전염병 차원으로 취급하고 있어 비만은 전 세계가 안고 있는 공통의 문제라고 하겠다. 비만은 고혈압, 당뇨 등 성인병의 원인이 되고 있어 비만의 문제를 해결하기 위해서는 식생활의 개선이 이루어져야 함은 물론이며 적절한 다이어트 식 품이 절실히 필요한 실정이다.In 2000, 32.7% (33.1% of males and 32.2% of females) among Seoul citizens were classified as obese, and the rate of obesity among Korean adults is increasing by 3% every year. According to the WHO, Korean childhood obesity has more than doubled in 10 years, and there has been a significant increase in moderate to severe obesity. American society is calling for the need for a new nutritional program due to the widespread problem of child obesity, and treating obesity of children as an epidemic. Obesity is a common problem in the world. Obesity is a cause of adult diseases such as hypertension and diabetes, and in order to solve the problem of obesity, of course, the diet should be improved, and proper diet food is urgently needed.
실제로 소비자들이 변비 해소 및 다이어트에 목적을 두고 초콩류의 제품을 구매하고 있는 등 전체 다이어트 시장의 규모는 날로 커지고 있다. 우리나라 Beauty 산업의 국내 시장규모는 무려 26조 4천억 원으로 추정하며, 이 중에서 다이어트 시장은 1조원 규모로 예상하고 있다(삼성경제연구소의 발표). 미국의 경우, 비만을 줄이려는 다이어트 시장은 자동차 시장의 26배로 추정되고 있는바, 미국 내 자동차 시장규모를 연 3,000억 달러로 추산한다면, 무려 7조8,000억 달러에 이르는 규모이다(1999. 갤럽조사). 중국의 다이어트 제품 시장은 음식과 의약품을 병행한 것이 주류를 이루고 있으며 전통 한의약에 서방의약을 결합한 제품으로 독창적인 시장을 형성해오고 있다. 비만증 확대에 따라 중국 다이어트 식품 시장도 급성장을 보여 현재 다이어트시장이 전국 보건식품시장의 절반 이상을 차지, 연간 시장규모가 195억 위안(23억6천만 달러)에 달하고 있다(자료원: 中國經濟週刊 2002. 10. 30. 消費日報).In fact, the total diet market is growing day by day, with consumers buying confectionary products for the purpose of relieving constipation and dieting. The domestic market size of Korea's beauty industry is estimated at 26.44 trillion won, of which the diet market is estimated at 1 trillion won (Samsung Economic Research Institute). In the United States, the diet market to reduce obesity is estimated to be 26 times that of the automobile market. If the US automobile market is estimated at US $ 300 billion annually, it is worth US $ 7.7 trillion (1999. Gallup Survey) ). The diet product market in China is mainly made up of a combination of food and medicine, and has been forming an original market by combining traditional Chinese medicine with Western medicine. As China's diet food market is growing rapidly due to the increase in obesity, the diet market accounts for more than half of the nation's health food market, and the annual market size is 19.5 billion yuan (US $ 2.36 billion) (Source: 中國 經濟 週刊 2002 10. 30. 消費 日報).
한편, 대두는 단백질 약 35%, 지방 17%와 탄수화물 31% 외에 phytochemical, saponin, trypsin inhibitor, 올리고당, 식이섬유 등의 비영양소인 생리활성물질을 함유하고 있다. 콩은 양질의 단백질과 성인병을 예방할 수 있는 다양한 기능성 물질을 함유하고 있어 콩의 생리 기능성 물질에 대한 연구가 활발히 진행되었다. 콩은 angiotensin converting enzyme(ACE) 저해작용으로 고혈압을 예방하며, 강력한 혈전용해능이 있어 비만과 심혈관계 질환의 예방에 효과적이며 다이어트 식품으로 적합한 식품이다.Soybean contains about 35% protein, 17% fat and 31% carbohydrate, and contains bioactive substances that are non-nutrients such as phytochemical, saponin, trypsin inhibitor, oligosaccharide, and dietary fiber. Soy contains high-quality protein and various functional substances that can prevent adult diseases. Soybeans are angiotensin converting enzyme (ACE) inhibitory action to prevent hypertension and strong thrombolytic ability to prevent obesity and cardiovascular diseases and is a suitable food for diet.
위와 같이 다양한 생리활성 물질을 함유한 콩을 건강식품으로 이용하는 예는 두부, 청국장 등이 있다. 최근에 우리나라에서 새로운 콩 발효식품으로 생콩을 식초에 절인 식초콩이 나왔는데, 콩 본래의 영양성분을 그대로 간직하면서 식초와 함께 발효하는 과정을 통하여 잘 이용되지 못하던 거대분자의 유용성분이 작은 분자로 분해되는 과정을 거침으로써 체내 이용성을 높여주는 식초콩이 개발되어 변비를 개선하고 비만억제에 효과적인 다이어트 식품으로 각광을 받고 있다. 이에 본 발명의 발명자는 식초콩의 제조과정에서 적정 제조조건을 수립하였다.Examples of using soybeans containing various bioactive substances as health foods include tofu and cheonggukjang. Recently, a new soybean fermented food in Korea has been introduced vinegar soybeans pickled raw vinegar, the useful components of macromolecules that were not used well through the process of fermentation with vinegar while retaining the original nutrients of soybeans are decomposed into small molecules By going through the process, vinegar soybeans have been developed to improve the usability of the body, which has been in the spotlight as an effective diet food for improving constipation and suppressing obesity. Therefore, the inventor of the present invention established the proper manufacturing conditions in the manufacturing process of vinegar beans.
현재 국내에는 식초콩의 제조에 관하여 몇 건의 특허가 등록되어 있으며 야채즙과 간장, 설탕, 향미제 등을 첨가하여 신맛을 완화시키는 방법으로 식초콩을 제조하는 기술도 소개되었다. 그러나 기존의 기술은 간장, 야채즙과 조미액을 사용한 식초콩의 제조방법이며 한약재를 첨가하는 방법으로는 아직 개발된 것이 없다.Currently, several patents have been registered in Korea regarding the production of vinegar beans, and the technology of manufacturing vinegar beans by introducing vegetable juice, soy sauce, sugar, and flavoring to alleviate the sour taste. However, the existing technology is a method of manufacturing vinegar beans using soy sauce, vegetable juice and seasoning liquid, and has not yet been developed as a method of adding herbal medicines.
'가야원식품'은 대표이사의 이름으로 초란칼슘환의 제조방법에 관한 특허를 출원한 바 있으며(2006. 4. 6., 특허출원 제10-2006-0031209호, 흑태와 란칼슘 농축액을 성분으로 하는 흑태초란칼슘환의제조 방법) 건강기능성 식품의 개발을 위하여 한약재를 첨가하는 방법을 구상 중에 있었으나 적절한 제조조건을 결정하는 데 여러 가지 어려움이 있어 본 발명의 발명자가 컨소시엄 과제를 통해 한약재를 첨가한 한방초콩환을 제조하게 되었다.'Kayawon Food' has filed a patent on the method of manufacturing a calcium calcium ring in the name of its representative director (April 6, 2006, Patent Application No. 10-2006-0031209, Concentrate of Black Tae and Lan Calcium Concentrates) Method of manufacturing the black taechoranran calcium ring) The method of adding a herbal medicine for the development of health functional food, but there are various difficulties in determining the appropriate manufacturing conditions, the inventor of the present invention added the herbal medicine through a consortium task The soybean rings were prepared.
현재 판매 중인 식초콩은 소비자들의 경험을 통하여 변비와 다이어트 효과가 알려지고 있으나 동물실험을 통하여 검증된 자료는 부족한 실정이다. 따라서 본 연구를 통하여 개발한 식초콩 제품은 동물실험을 통하여 효과를 검증함으로써 믿을 수 있는 건강식품으로서의 가치를 나타낼 것으로 예상되므로 동물 실험을 함께 실시하여 효능검증 실험을 실시하였다.The vinegar soybeans currently on sale are known for their constipation and diet effects through consumer experience, but the data verified through animal experiments are insufficient. Therefore, the vinegar soybean product developed through this study is expected to show its value as a reliable health food by verifying its effectiveness through animal experiments.
본 발명의 목적은, 콩과 한약재를 적절히 조합하여 다이어트 효과 등 다양한 기능성을 가지면서도 제품의 맛과 품질에서 소비자들이 복용하기에 편리하도록 한, 한약재를 첨가한 기능성 식초콩 환 제품의 제조방법을 제공하는 데 있다.It is an object of the present invention to provide a method for producing a functional vinegar soybean pill product, which has been added to the combination of soybean and medicinal herbs, so that it is convenient for consumers to take in the taste and quality of the product while having various functionalities such as diet effect. There is.
상기한 목적을 달성하기 위한 본 발명은,The present invention for achieving the above object,
콩을 식초에 절인 후 수분 함량이 15% 이하가 될 때까지 건조시키는 단계;Pickling the beans in vinegar and drying until the moisture content is 15% or less;
위 단계와 별도로 계란 껍질을 순수 식초에 녹여서 난칼슘식초를 준비하는 단계;Preparing egg calcium vinegar by dissolving the egg shell in pure vinegar separately from the above step;
위에서 건조한 초콩의 분말과 산수유, 백출, 산조인, 황기, 감초의 5가지 한약재 분말을 준비한 난칼슘식초와 함께 반죽하는 단계;Kneading with dried calcium vinegar prepared from the powder of dried soybeans and five herbs powders such as cornus, baekchul, sanjoin, Astragalus, licorice;
위 반죽물로 환을 만들어 건조시키는 단계;를 포함하는 한방 초콩환의 제조방법인 것을 특징으로 한다.It is characterized by the method of producing a herbal soybean pill including the step; making a ring to dry with the dough.
이때, 건조한 초콩의 분말과 산수유, 백출, 산조인, 황기, 감초의 5가지 한약재 분말을 난칼슘식초와 함께 반죽함에 있어서, 초콩의 분말과 한약재 분말의 혼 합비율은 중량비로 90:2:2:2:2:2인 것을 특징으로 한다.At this time, when mixing five kinds of herbal medicine powder of dried soybean powder and cornus oil, white extract, Sanjoin, Astragalus, licorice with egg calcium vinegar, the mixing ratio of the soybean powder and herbal medicine powder is 90: 2: 2: 2: 2: 2.
또한, 위에서 사용하는 콩은 서목태인 것을 특징으로 한다.In addition, the beans used in the above is characterized in that the Seomoktae.
또한, 콩을 식초에 절이는 기간은 15일인 것을 특징으로 한다.In addition, the period of pickling beans in vinegar is characterized in that 15 days.
위에서 밝혔지만 난칼슘식초는 계란 껍질을 순수 식초에 충분히 녹여서 제조되는 식초를 말한다. 더욱 상세하게는 계란 껍질을 수거하여 따뜻한 물로 깨끗이 씻은 다음 건조시켜서 곱게 빻은 후, 이를 식초에 녹이는 과정을 거쳐 제조된다. 난칼슘식초를 사용할 경우 제품의 칼슘 함량이 증가되기 때문에 더욱 바람직하다.As mentioned above, egg calcium vinegar refers to vinegar prepared by melting egg shells in pure vinegar. More specifically, the egg shells are collected, washed with warm water, dried, ground and ground, and then prepared by dissolving them in vinegar. The use of egg calcium vinegar is more preferable because the calcium content of the product is increased.
본 발명에 따르면, 초콩과 한약재를 적절히 활용하여 다이어트 효과, 항암 성능, 항상화 성능 등 다양한 기능성을 가지면서도 제품의 맛과 품질에서 소비자들이 복용하기에 편리한 기능성 식초콩 환 제품을 획득할 수 있다.According to the present invention, it is possible to obtain a functional vinegar soybean pill product that is convenient for consumers to take in the taste and quality of the product while having various functionalities such as diet effect, anticancer performance, homeostasis performance by appropriately using the soybean and herbal medicine.
이를 통해 노화를 지연시키는 등 성인병 예방에 좋은 효과를 나타낼 수 있고, 특히 맛과 품질 개선을 통해 일반인들이 거부감 없이 복용할 수 있도록 하였기 때문에 건강식품으로서의 가치를 지니고 있다 하겠다.Through this, it can have a good effect on preventing adult diseases such as delaying aging. Especially, it has a value as a health food because it can be taken by the general public without objection through improvement of taste and quality.
더 넓게는 국내의 농가에서 생산되는 콩(서목태)을 활용한 제품으로 농가소득을 증가시키고 한약재 재배농가의 소득을 증가시킬 수 있으며 세계 각국의 건강식품 혹은 다이어트 식품시장 진출에 기여를 할 수 있을 것으로 생각된다.More broadly, products using soybeans (seomoktae) produced by domestic farmers can increase farmers' income, increase incomes of medicinal herb farmers, and contribute to the entry of healthy or diet food markets around the world. do.
이하 발명에 이른 경위와 관련 실험을 통해 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail through the process and related experiments.
제1장 과제개발 내용 및 방법Chapter 1 Contents and Methods of Task Development
제1절 Section 1 초콩에On the beans 첨가하는 한약재의 선정 Selection of herbal medicines to add
1. 한약재 추출물의 기능성 실험1. Functional Experiment of Herbal Extracts
한방초콩 제조를 위하여 비만치료 및 예방 효능을 가진 것으로 보고된 한약재 중에서 식품으로 사용할 수 있는 8종의 한약재를 선택하여 물과 에탄올로 추출하여 여러 가지 기능성 실험을 위한 시료로 사용하였다. Among the herbal medicines reported to have anti-obesity treatment and preventive effects for the manufacture of herbal soybeans, eight kinds of herbal medicines that can be used as food were selected, extracted with water and ethanol, and used as samples for various functional experiments.
2. 한약재 추출물의 2. Herbal Medicine Extract 항산화능Antioxidant activity 측정 Measure
한약재의 물과 에탄올 추출물로서 전자공여능을 측정하였다. The electron donating ability was measured as water and ethanol extract of the herbal medicine.
<그림 1>은 한약재 물추출물의 항산화능으로 산조인 추출물이 100ppm의 저농도에서도 70% 이상의 높은 항산화능을 나타내었고, 산조인, 백출, 산수유, 황기, 감초, 황금의 물추출물은 모두 1,000ppm 농도에서 80% 이상의 높은 전자공여능을 나타내었으며 백복령의 물추출물은 1,000ppm에서 73.5%의 전자공여능을 나타내었다.<Figure 1> shows the antioxidative activity of the water extracts of medicinal herbs, and the acid extracts showed high antioxidant activity at over 70% even at low concentrations of 100ppm. It showed high electron donating ability of more than% and the water extract of Baekbokyeong showed 73.5% of electron donating ability at 1,000ppm.
<그림 1> 한약재 <Figure 1> Herbal Medicine 물추출물의Water extract 전자공여능Electron donating ability
<그림 2>는 한약재 에탄올추출물의 전자공여능을 나타내었다. 백출, 감초 추출물은 1,000ppm에서 90% 이상의 높은 항산화능을 나타내었으며 산조인, 황기, 백복령은 1,000ppm에서 80% 이상의 항산화능을 나타내었고, 황금 추출물은 1,000ppm에서 72%의 전자공여능을 나타내었다.<Figure 2> shows the electron donating ability of the herbal ethanol extract. White extract and licorice extract showed high antioxidant capacity over 90% at 1,000ppm. Sanjoin, Astragalus and Baekbokryeong showed more than 80% antioxidant activity at 1,000ppm, and golden extract showed 72% electron donating ability at 1,000ppm.
<그림 2> 한약재 에탄올추출물의 <Figure 2> Herbal Medicine Ethanol Extract 전자공여능Electron donating ability
3. 한약재 추출물의 항암활성 측정3. Anticancer Activity of Herbal Extracts
1) 유방암세포(1) breast cancer cells ( MDAMDA cellcell )에 대한 항암활성Anticancer activity against
<그림 3>은 유방암세포(MDA cell)에 대한 한약재 물추출물의 항암활성을 나타내었다. 추출물1,000 ppm 농도에서 백출 50%, 감초 45%, 산수유 42%, 황기 39%, 산조인 30%의 순으로 높은 항암활성을 나타내었다. <Figure 3> shows the anticancer activity of medicinal herb extracts against breast cancer cells (MDA cells). The extract showed high anticancer activity in the order of 1000 ppm of white extract, 45% of licorice, 42% of cornus oil, 39% of Astragalus, and 30% of Sanjoin.
<그림 3> 한약재 <Figure 3> Herbal Medicine 물추출물의Water extract 유방암세포( Breast cancer cells MDAMDA cellcell )에 대한 항암활성Anticancer activity against
<그림 4>는 유방암세포(MDA cell)에 대한 한약재 에탄올추출물의 항암활성을 나타내었다. 에탄올 추출물 역시 백출추출물의 항암활성이 가장 높았는데 1,000ppm에서 40%의 항암활성을 나타내었으며, 그 다음으로 산조인, 산수유, 황기, 감초 추출물이 1,000ppm에서 각각 31.5%, 28%, 33%, 35%의 항암활성을 나타내었다.<Figure 4> shows the anticancer activity of the medicinal herb ethanol extract against breast cancer cells (MDA cells). Ethanol extract also showed the highest anticancer activity of white extract, showing 40% anticancer activity at 1,000ppm, followed by Sanjoin, Cornus, Astragalus, and Licorice extract at 31.5%, 28%, 33%, 35 at 1,000ppm, respectively. It showed% anticancer activity.
<그림 4> 한약재 에탄올추출물의 유방암세포(<Figure 4> Breast Cancer Cells of Ethanol Extract of Herbal Medicine ( MDAMDA cellcell )에 대한 항암활성Anticancer activity against
2) 폐암세포(A549 2) Lung Cancer Cells (A549) cellcell )에 대한 항암활성Anticancer activity against
<그림 5>는 한약재 물추출물의 폐암세포(A549 cell)에 대한 항암활성을 나타내었다. 백출추출물은 1,000 ppm에서 43.5%의 항암활성을 나타내었으며, 그 다음으로 산수유, 황기, 감초 추출물이 1,000 ppm에서 31~34%의 항암활성을 나타내었다.<Figure 5> shows anticancer activity of lung cancer cells (A549 cell) of water extract of medicinal herbs. The white extract showed anticancer activity of 43.5% at 1,000 ppm, followed by cornus, astragalus and licorice extracts at 31 ppm to 34% at 1,000 ppm.
<그림 5> 한약재 <Figure 5> Herbal Medicine 물추출물의Water extract 폐암세포(A549 Lung cancer cell (A549) cellcell )에 대한 항암활성Anticancer activity against
<그림 6>은 한약재 에탄올추출물의 폐암세포(A549 cell)에 대한 항암활성을 나타내었다. 백출추출물은 1,000 ppm에서 40%의 항암활성을 나타내었으며, 그 다음으로 감초, 황기, 산조인 추출물이 1,000 ppm에서 32~36%의 항암활성을 나타내었다.<Figure 6> shows anticancer activity of lung cancer cells (A549 cell) of ethanol extract of herbal medicine. The white extract showed 40% anticancer activity at 1,000 ppm, followed by licorice, Astragalus and Sanjoin extracts at 32 ppm to 36% at 1,000 ppm.
<그림 6> 한약재 에탄올추출물의 폐암세포(A549 <Figure 6> Lung Cancer Cells from the Herbal Medicine Ethanol Extract (A549) cellcell )에 대한 항암활성Anticancer activity against
4. 한약재의 선정4. Selection of Herbal Medicines
한약재의 물과 에탄올 추출물로서 항산화능과 항암활성에 대한 실험 결과(그림 1~그림 6)에서 기능성이 우수한 한약재 5종(산조인, 백출, 산수유, 황기, 감초)을 선정하여 초콩환 제조에 사용하기로 하였다.Water and ethanol extracts of herbal medicines were selected for the five functional herbal medicines (sanjoin, baekchul, cornus, coriander, licorice) from the results of antioxidant and anticancer activity (Fig. It was set as.
제2절 Section 2. 식초콩Vinegar Beans 절임기간Pickling period 및 콩의 종류 검토 And types of beans review
1. 식초절임 기간에 따른 기호도의 변화1. Changes in taste degree according to pickling period
흑태, 서리태, 서목태를 현미식초에 15일간 절이면서 저장기간에 따른 기호도(경도, 신맛, 비린맛, 종합적인 기호도)의 변화를 조사한 결과는 <그림 7>과 같다. 저장기간이 길수록 기호도가 증가하였으며 절임 15일에 3종류의 콩이 모든 평가항목에서 가장 높은 점수를 얻었기 때문에 식초절임 기간은 15일이 적합할 것으 로 생각되었다.The results of examining the change of preference (hardness, sour taste, fishy taste, overall taste degree) according to the storage period of black brown, Seoritae, and Seomoktae in brown rice vinegar for 15 days are shown in <Figure 7>. The longer the storage period, the higher the degree of preference and 15 days of pickling was considered to be appropriate because three types of soybeans scored highest on all evaluation items.
<흑태> <Black body>
<서리태> <Surtae>
<서목태> <Seomoktae>
<그림 7> <Figure 7> 흑태Black Tae , , 서리태Seo-tae , , 서목태의Seomoktae 식초절임Pickled vinegar 기간에 따른 기호도 변화 Favorability change with period
2. 2. 식초절임Pickled vinegar 과정에서 콩 품종에 따른 Depending on the bean varieties in the process GenisteinGenistein 함량변화 Change in content
한방초콩환 제조에 적합한 콩을 선별하기 위하여 흑태, 서리태, 서목태 등 3종류의 콩을 식초에 15일간 절이면서 Genistein 함량의 변화를 조사한 결과, 15일간 절인 콩의 Genistein 함량이 가장 높았다.In order to select suitable soybeans for Chinese herbal soybean pill, three kinds of soybeans such as black, sori and seomoktae were pickled in vinegar for 15 days and the change of genistein content was examined.
3. 콩의 종류와 3. Types of Beans 절임기간Pickling period 설정 Set
서목태를 현미식초에 15일간 절인 것이 맛이 좋고, Genistein 함량이 가장 높았으므로 콩은 서목태를, 절임기간은 15일간 현미식초에 절여서 초콩환 제조에 사용하였다. Seomoktae was pickled in brown rice vinegar for 15 days, and the highest content of Genistein was shown. Soybeans were used to make soybean pill, pickled in brown rice vinegar for 15 days.
제3절 한방 Section 3 Oriental Medicine 초콩환의Chocolate beans 제조방법 설정 Manufacturing method setting
1. 한약재 첨가비율에 따른 1. Medicinal Herb Addition Ratio 초콩환의Chocolate beans 기호도 조사 Survey sign
초콩환의 제조를 위하여 사용했던 한약재 5종(산수유, 백출, 산조인, 황기, 감초)의 분말을 각각 중량비율로 1%(콩 분말 95%), 2%(콩 분말 90%), 3%(콩 분말 85%) 첨가하였다. 그리하여 초콩분말을 순수 식초로 제조한 초콩환(제품A), 초콩분말과 한약재 분말 5종을 각각 1%씩 첨가하여 난칼슘식초로 제조한 초콩환(제품C), 초콩분말과 한약재 분말 5종을 각각 2%씩 첨가하여 난칼슘식초로 제조한 초콩환(제품D), 초콩분말과 한약재 분말 5종을 각각 3%씩 첨가하여 난칼슘식초로 제조한 초콩환(제품E)을 준비하여 색상, 신맛, 한약재맛, 쓴맛, 뒷맛, 총괄평가에 대한 기호도를 7점법으로 조사하였다. 결과는 <표 1>과 같다.Powders of five kinds of Chinese herbal medicines (Hansuyu, Baekchul, Sanjoin, Astragalus, Licorice), which were used for the production of Chokong Soybean Ring, were 1% (95% soybean powder), 2% (90% soybean powder) and 3% (soybean) in weight ratio, respectively. Powder 85%). Thus, the soybean powder (product A) made with pure vinegar, the soybean powder (product C) made with non-calcium vinegar by adding 1% each of the soybean powder and herbal medicine powder, 5 kinds of soybean powder and herbal medicine powder Add 2% of each to prepare a soybean pill (product D) made with egg calcium vinegar, and a soybean powder (product E) made with egg calcium vinegar by adding 3% each of 5 kinds of powdered soybean powder and medicinal herbs. The preference of sour, sour, medicinal herb, bitter, aftertaste, and overall evaluation were examined by 7-point method. The results are shown in Table 1.
한약재를 첨가한 초콩환의 첨가비율에 따른 기호도 조사에서 한약재의 첨가비율에 따른 각 항목 간에 유의적인 차이는 나타나지 않았으나 한약재의 첨가비율이 3%로 높일 경우에는 색상에 대한 기호도 점수가 유의적으로 감소하였으므로 한약재의 첨가비율은 2%씩 첨가하는 것(제품 D)을 최종제품으로 결정하였다.In the palatability study according to the addition ratio of herbal soybeans added with herbal medicine, there was no significant difference between the items according to the addition ratio of herbal medicine, but when the addition ratio of herbal medicine increased to 3%, the preference score for color decreased significantly. The addition ratio of the herbal medicine was determined to add 2% each (product D) as the final product.
제4절 Section 4 한방초콩환Herbal Choco Beans 추출물의 기능성 검토 Functional Review of Extracts
1. One. 한방초콩환Herbal Choco Beans 추출물의 Of extract 항산화능Antioxidant activity
한방초콩환의 제조단계별로 원료인 콩 ( 서목태 ), 서목태를 15일간 절인 콩( 초콩 ), 초콩을 난칼슘-식초로서 반죽하여 만든 환( 초콩환 ) 및 초콩과 5종의 한약재(산조인, 백출, 산수유, 황기, 감초)를 각각 2%씩 첨가하여 난칼슘-식초로서 제조한 한방초콩환(제품 D) 을 물과 에탄올로서 추출하여 각각의 항산화능(전자공여능, SOD 유사활성, 아질산염소거능)을 측정하였다. Oriental chokong ring raw material soybeans manufacturing step (seomoktae) seomoktae the 15 days Canned beans (chokong), I calcium to chokong-ring made of dough as vinegar (chokong Exchange) and chokong and five species of medicinal plants (sanjoin, baekchul, Extracts of Chinese herbal soybean pill (Product D) prepared as egg calcium-vinegar by adding 2% of cornus oil, Astragalus, and licorice respectively , as water and ethanol, and the antioxidant activity (electron donating ability, SOD-like activity, nitrite scavenging ability ) was extracted. Measured.
2. 2. 한방초콩환Herbal Choco Beans 추출물의 항암활성 Anticancer Activity of Extracts
한방초콩환의 물과 에탄올 추출물로서 유방암세포(MDA cell)와 폐암세포(A549 cell)에 대한 항암활성을 측정하였다. The anticancer activity of breast cancer cells (MDA cells) and lung cancer cells (A549 cells) was measured as extracts of herbal and soybean pills .
3. 3. 한방초콩환Herbal Choco Beans (제품 D) 추출물의 기능성은 (Product D) The functionality of the extract 항산화능과Antioxidant activity 항암활성 모두 콩 추출물이 나 순수식초로 반죽한 초콩환에 비하여 Compared with the soybean paste kneaded with soy extract or pure vinegar 항산화능과Antioxidant activity 항암활성이 증가하였다. Anticancer activity increased.
제5절 Section 5 한방초콩환의Herbal soybean 효능검증을 위한 동물실험 Animal experiment for efficacy verification
1. 재료 및 방법1. Materials and Methods
1) 실험동물1) Experimental Animal
실험동물은 대한실험동물센터에서 5주령된 수컷 흰쥐(Sprague-Dawley계)를 분양받아 온도 22±2℃,습도 53±3%및 밤낮을 12시간씩 조절하여 물과 사료를 충분히 공급하면서 1주간 실험실에 적응시킨 다음 체중이 비슷한 개체만을 선정하여 사용하였다.Experimental animals were fed 5 week-old male rats (Sprague-Dawley system) at the Korea Experimental Animal Center for 1 week while supplying sufficient water and feed by adjusting temperature 22 ± 2 ℃, humidity 53 ± 3% and day and night for 12 hours. After adapting to the laboratory, only individuals of similar weight were selected and used.
2) 비만 유도 및 사료조제2) Obesity Induction and Feed Preparation
한방초콩환 분말의 일반성분은 <표 2>와 같으며 실험동물 7마리씩을 일반사료(AIN-76조성에 따라 조제) 급여군(Normal group), 고지방사료를 급여한 대조군(HF group), 초콩환 분말 1%를 첨가하여 고지방사료로 급여한 실험군(Treatment group, T-1), 초콩환 분말 5%를 첨가하여 고지방사료로 급여한 실험군(Treatment group, T-5)으로 배정하였다.The general components of herbal herbal soybean pill powder are shown in <Table 2> Test (in accordance with AIN-76 composition prepared) the animal 7 normal rats of feeding the group (Normal group ), control group fed high fat diet ( HF group ), the experimental group fed with high-fat feed with 1% of soybean pill powder (Treatment group, T-1 ), and the trial group ( T-5 ) fed with high-fat feed with 5% of kong bean powder. It was.
정상군은 일반사료를 충분히 공급하면서 9주간 사육하였고 고지방식이군(HF)은 다음과 같이 한국인의 식사경향을 고려하여 조제한 고지방사료만을 충분히 공급하며 9주간 사육하였다. 실험군은 고지방식이군과 같은 고지방 사료에 한방초콩환의 성분<표 2>를 고려하여 한방초콩환을 각각 1%(T-1), 5%(T-5) 첨가한 사료를 충 분히 공급하면서 9주간 사육하였으며 사료의 kg당 조성 내용과 분량은 <표 3>과 같다.The normal group was fed for 9 weeks while supplying enough general feed, and the high-fat diet group (HF) was raised for 9 weeks, supplying only high fat foods prepared in consideration of the eating trend of Koreans as follows. The experimental group supplied enough feeds containing 1% (T-1) and 5% (T-5) Chinese herbal soybean rings to high-fat diets such as the high-fat diet group <Table 2>. The contents and quantity per kg of feed were bred weekly and are shown in <Table 3>.
3) 채혈 및 장기 무게 측정3) Blood collection and organ weight measurement
희생 전 15시간 절식시킨 후 복부 대동맥으로부터 채혈하여 혈청을 분리하였으며 간과 부위별 내장지방을 신속하게 분리해 낸후 무게를 측정하였다.Serum was isolated from the abdominal aorta by fasting for 15 hours before sacrifice, and the visceral fat was rapidly separated from the liver and site, and weighed.
제2장 성과Chapter 2. Achievements
제1절 기능성이 우수한 Section 1 excellent functionality 한방초콩환Herbal Choco Beans 개발 Development
1. One. 항산화능이Antioxidant activity 우수한 Excellent 한방초콩환Herbal Choco Beans 개발 Development
한방초콩환의 제조단계별로 원료인 콩 ( 서목태 ), 서목태를 15일간 절인 콩( 초콩 ), 초콩을 난칼슘- 식초로서 반죽하여 만든 환( 초콩환 ) 및 초콩과 5종의 한약재(산조인, 백출, 산수유, 황기, 감초)를 각각 2%씩 첨가하여 난칼슘-식초로서 제조한 한방초콩환 을 물과 에탄올로서 추출하여 각각의 기능성(항산화능, 아질산염소거능, 항암활성)을 측정하였다. Oriental chokong ring raw material soybeans manufacturing step (seomoktae) seomoktae for 15 days Canned beans (chokong), I calcium to chokong-ring made of dough as vinegar (chokong ring) and chokong and five species of medicinal plants (sanjoin, baekchul, Corn oil, Astragalus, and licorice) were added 2% each to extract the herbal vinegar soybean prepared as egg calcium-vinegar as water and ethanol to measure the respective functionalities (antioxidant activity, nitrite scavenging ability, anticancer activity).
1) One) 전자공여능Electron donating ability
<그림 8>은 각 시료 물추출물의 전자공여능을 나타내었다. 각 추출물의 1,000 ppm에서 전자공여능은 서목태 69%, 초콩환은 73.5%로 서목태 추출물보다 약간 증가하였으며, 최종제품인 한방초콩환 추출물은 82%로서 서목태에 비해 13%의 전자공여능 증가를 나타내었다.<Figure 8> shows the electron donating ability of each sample water extract. At 1,000 ppm of each extract, the electron donating ability was 69% in Seomoktae and 73.5% in the soybean ring, slightly higher than that of Seomoktae extract.
<그림 8> 제조과정별 각 시료 <Figure 8> Samples by Manufacturing Process 물추출물의Water extract 전자공여능Electron donating ability
<그림 9>는 각 시료 에탄올추출물의 전자공여능을 나타낸 결과로서 각 추출물 1,000 ppm 농도에서 전자공여능은 서목태 76%, 초콩환은 82%로 서목태 추출물보다 약간 증가하였으며, 최종제품인 한방초콩환 추출물은 94%로 서목태에 비해 18%의 전자공여능 증가를 나타내었다. 특히 에탄올추출물은 물추출물에 비하여 7~12% 높은 전자공여능을 나타내었다.<Figure 9> shows the electron donating ability of ethanol extract of each sample. At 1,000 ppm concentration of each extract, the electron donating ability was 76% of Seomoktae and 82% of soybean rings, slightly higher than that of Seomoktae extract. As a result, the electron donating ability was increased by 18%. In particular, ethanol extract showed 7-12% higher electron donating ability than water extract.
<그림 9> 제조과정별 각 시료 에탄올추출물의 <Figure 9> Ethanol Extracts of Each Sample by Manufacturing Process 전자공여능Electron donating ability
2) 2) SODSOD (( SuperoxideSuperoxide dismutasedismutase ) ) 유사활성Pseudo-activity
<그림 10>은 각 시료 물추출물의 SOD 유사활성을 측정한 결과로서 각 추출물 1,000 ppm 농도에서 전자공여능은 서목태와 초콩이 약 40%, 초콩환은 44%였으며, 한방초콩환은 46%로 서목태에 비해 6% 높은 활성을 나타내었다. 특히 에탄올추출물은 물추출물에 비하여 7~12% 높은 SOD 유사활성을 나타내었다.<Figure 10> shows the SOD-like activity of the water extracts of each sample. At 1,000 ppm of each extract, the electron donating ability was about 40% for Seomoktae and soybeans, 44% for the soybean rings, and 46% for herbal soybean rings, compared to Seomoktae. 6% higher activity. In particular, ethanol extract showed 7-12% higher SOD-like activity than water extract.
<그림 10> 제조과정별 각 시료 <Figure 10> Samples by Manufacturing Process 물추출물의Water extract SODSOD 활성 activation
<그림 11>은 각 시료 에탄올추출물의 SOD활성을 측정한 결과로서 각 추출물 1,000 ppm 농도에서 전자공여능은 서목태 43%, 초콩이 48%, 초콩환은 49%였으며, 한방초콩환은 56%로 서목태에 비해 13% 높은 활성을 나타내었다. 에탄올추출물은 물추출물보다 2~10% 높은 SOD활성을 나타내었다.<Figure 11> shows the result of measuring the SOD activity of each sample ethanol extract. At 1,000 ppm of each extract, the electron donating ability was 43% of Seomoktae, 48% of soybeans, 49% of soybean rings, and 56% of herbal soybean rings compared to Seomoktae. 13% higher activity. Ethanol extract showed 2-10% higher SOD activity than water extract.
<그림 11> 제조과정별 각 시료 에탄올추출물의 <Figure 11> Ethanol Extracts of Each Sample by Manufacturing Process SODSOD 활성 activation
3) 3) 아질산염소거능Nitrite scavenging ability
<그림 12>는 각 시료 물추출물의 pH 1.2에서 농도별 아질산염소거능으로서 서목태가 54%로 가장 높았고 다음은 한방초콩환(52%), 초콩환(49%), 초콩(43%)의 순이었다. <Figure 12> showed the highest nitrite quenching ability by concentration at pH 1.2 of each sample, with 54% of Seomoktae followed by Chinese herbal soybean (52%), soybean (49%), and soybean (43%). .
<그림 13>에서 각 시료 에탄올추출물의 pH 1.2에서 아질산염소거능은 서목태가 61%로 가장 높았고 다음은 한방초콩환(55%), 초콩환(49%), 초콩(43%)로서 에탄올추출물의 아질산염소거능이 물추출물에 비하여 약간 높은 편이었다.In <Figure 13>, the nitrite scavenging ability at pH 1.2 of each sample ethanol extract was the highest in Seomoktae (61%), followed by herbal soybean rings (55%), soybean rings (49%), and soybeans (43%). Scavenging activity was slightly higher than water extract.
<그림 12> 제조과정별 각 시료 <Figure 12> Samples by Manufacturing Process 물추출물의Water extract 아질산염 nitrite 소거능Scavenging power
<그림 13> 제조과정별 각 시료 에탄올추출물의 아질산염 <Figure 13> Nitrite of Ethanol Extract of Each Sample by Manufacturing Process 소거능Scavenging power
2.2. 항암작용이 우수한 Excellent anticancer activity 한방초콩환Herbal Choco Beans 개발 Development
1) One) 한방초콩환Herbal Choco Beans 추출물의 유방암세포( Extract of breast cancer cells ( MDAMDA cellcell )에 대한 항암활성Anticancer activity against
<그림 14>는 각 시료 물추출물의 유방암세포(MDA cell)에 대한 항암활성을 나타내었다. 각 추출물의 1,000 ppm에서 항암활성은 서목태 49%, 최종제품인 한방초콩환 추출물은 52%로서 서목태에 비해 3%의 증가를 나타내었다.Figure 14 shows the anticancer activity of each sample water extract against breast cancer cells (MDA cells). At 1,000 ppm of each extract, the anticancer activity was 49% in Seomoktae and 52% in the herbal herbal soybean pill extract, which was 3% higher than that of Seomoktae.
<그림 14> 제조과정별 각 시료 <Figure 14> Samples by Manufacturing Process 물추출물의Water extract 유방암세포( Breast cancer cells MDAMDA cellcell )에 대한 항암활성Anticancer activity against
<그림 15>는 각 시료 에탄올추출물의 유방암세포(MDA cell)에 대한 항암활성을 나타내었다. 각 추출물의 1,000 ppm에서 항암활성은 서목태 38%, 최종제품인 한방초콩환 추출물은 41%로서 서목태에 비해 3%의 증가를 나타내었다.Figure 15 shows the anticancer activity of each sample of ethanol extract against breast cancer cells (MDA cells). At 1,000 ppm of each extract, the anticancer activity was 38% in Seomoktae and 41% in the herbal herbal soybean pill extract, which was 3% higher than Seomoktae.
각 추출물의 유방암세포(MDA cell)에 대한 항암활성 물추출물이 에탄올추출물에 비하여 약 10% 높은 편이었다.Anticancer active water extracts of MDA cells of each extract were about 10% higher than ethanol extracts.
<그림 15> 제조과정별 각 시료 에탄올추출물의 유방암세포(<Figure 15> Breast Cancer Cells of Ethanol Extracts of Each Sample MDAMDA cellcell )에 대한 항암활성Anticancer activity against
2) 2) 한방초콩환Herbal Choco Beans 추출물의 폐암세포(A549 Lung Cancer Cells of Extracts (A549) cellcell )에 대한 항암활성Anticancer activity against
<그림 16>은 각 시료 물추출물의 폐암세포(A549 cell)에 대한 항암활성을 나타내었다. 각 추출물의 1,000 ppm에서 항암활성은 서목태 35%, 초콩 32%, 초콩환 39%였으며 한방초콩환 추출물은 43%로서 서목태에 비해 8% 높은 활성을 나타내었다. Figure 16 shows the anticancer activity of lung cancer cells (A549 cells) of each sample water extract. At 1,000 ppm of each extract, the anticancer activity was 35% of Seomoktae, 32% of soybean, and 39% of soybean. The extract of oriental herbal soybean was 43%, which was 8% higher than that of Seomoktae.
<그림 16> 제조과정별 각 시료 <Figure 16> Samples by Manufacturing Process 물추출물의Water extract 폐암세포(A549 Lung cancer cell (A549) cellcell )에 대한 항암활성Anticancer activity against
<그림 17>은 각 시료 에탄올추출물의 폐암세포(A549 cell)에 대한 항암활성으로서 각 추출물의 1,000 ppm에서 항암활성은 서목태와 초콩은 30%, 초콩환 33%였으며 한방초콩환 추출물은 39%로서 서목태에 비해 9% 높은 활성을 나타내었으나 물추출물보다 항암활성이 낮은 편이었다. <Figure 17> shows the anticancer activity of lung cancer cells (A549 cell) of each sample ethanol extract. At 1,000 ppm of each extract, the anticancer activity was 30% for Seomoktae and soybeans, 33% for soybeans, and 39% for herbal soybean extracts. It showed 9% higher activity than Seomoktae, but showed lower anticancer activity than water extract.
<그림 17> 제조과정별 각 시료 에탄올추출물의 폐암세포(A549 <Figure 17> Lung Cancer Cells from Ethanol Extracts of Each Sample by Manufacturing Process (A549) cellcell )에 대한 항암활성Anticancer activity against
3. 다이어트 효과를 나타내는 3. Diet effect 한방초콩환Herbal Choco Beans 개발 Development
1) One) 한방초콩환이Chinese herbal choonghwan 고지방급여 흰쥐의 체중에 미치는 영향 Effect of High Fat on Rats on Body Weight
고지방 식이로 9주간 사육한 쥐(HF)의 체중 증가는 정상군에 비해 17% 증가하였으며, 한방초콩환 시료군(T-5)은 고지방식이군(HF)에 비해 체중이 9% 억제하였으나 정상군보다는 유의적인 차이는 없었다<표 4>.The weight gain of rats (HF) raised for 9 weeks on high fat diet was 17% higher than that of normal group, and the herbal cho soy pill sample group (T-5) suppressed 9% of body weight compared to HF. There was no significant difference than the group <Table 4>.
2) 2) 한방초콩환이Chinese herbal choonghwan 사료섭취량과 Feed intake and 식이효율(FER)에FER 미치는 영향 Impact
고지방식이군(HF)의 사료섭취량은 정상군에 비해 9% 감소하였으며, 시료군(T-5)은 고지방식이군(HF)과 사료섭취량이 비슷하였으나 유의성은 없었다.Feed intake of the high fat diet group (HF) was 9% lower than that of the normal group, and the sample group (T-5) was similar to the high fat diet group (HF), but there was no significant difference.
식이효율(FER)은 시료군(T-5)에서 고지방식이군(HF)에 비해 4% 감소하였으나 유의성은 없었다<표 5>.Dietary efficiency (FER) was decreased by 4% in the sample group (T-5) compared to the high-fat diet group (HF), but it was not significant (Table 5).
3) 3) 한방초콩환이Chinese herbal choonghwan 간의 무게 및 지방조직량에 미치는 영향 Effect on liver weight and fat tissue mass
고지방식이군(HF)의 간 무게는 정상군에 비해 34%가 많아서 유의적인 차이를 나타내었으며, 시료군(T-5)에서는 고지방식이군(HF)에 비해 간 무게는 13% 감소하였으나 정상군보다 20% 높은 편으로 모두 유의성은 없었다. 지방조직은 시료군(T-5)이 고지방식이군(HF)에 비해 부고환 지방이 15% 감소하였고, 내장지방은 23.4% 감소하여 고지방식이군(HF)에 비하여 유의적인 차이를 나타내었다<표 6>.The liver weight of the high-fat diet group (HF) was 34% higher than that of the normal group, showing a significant difference.In the sample group (T-5), the liver weight was reduced by 13% compared to the high-fat diet group (HF), but it was normal. There was no significant difference at 20% higher. In the adipose tissue, the epididymal fat decreased by 15% and visceral fat decreased by 23.4% in the T-5 group compared to the high fat diet group (HF), showing a significant difference compared to the high fat diet group (HF). 6>.
4) 4) 한방초콩환이Chinese herbal choonghwan 간 세포의 지방축적에 미치는 영향 Effect on Liver Cell Fat Accumulation
정상군(Normal)은 핵은 크고 둥글며 세포의 중앙에 위치해 핵질이 고르게 발달해 있고 세포질에는 난원형의 미토콘드리아를 비롯한 각종 세포 소기관의 형태가 분명하였고 정상세포 전반에 걸쳐 지방구는 보이지 않았다. 고지방식이군(HF)은 세포전반에 걸쳐 지방구에 뒤덮여 세포의 형태 관찰이 불가능할 정도였으며 지방구와 지방구 사이로 관찰한 세포질 내에도 지방의 과잉 축적으로 세포소기관의 막과 형태가 불분명한 지방간의 심각한 양상을 볼 수 있었다. In the normal group, the nucleus is large and round, and the nucleus is evenly developed in the center of the cell. The cytoplasm has a clear shape of various organelles including ovarian mitochondria and no fat cells in the normal cell. The high-fat diet group (HF) was covered with fat cells throughout the cell and was unable to observe the morphology of the cells. I could see the aspect.
고지방과 한방초콩환 1% 식이군(T1)은 HF군에 비하여 지방구가 많이 소멸되어 핵과 미토콘드리아 등 세포질의 관찰이 가능하였으나, 미토콘드리아 및 소포체의 막이 불분명하였다. 한방초콩환 5% 식이군(T5)은 T1에 비하여 지방세포의 크기와 수가 줄어들고 세포질의 지방질도 줄어들어 세포소기관의 형태가 더욱더 선명하였으며 지방질의 감소를 볼 수 있어 미토콘드리아의 수나 모양 그리고 조면소포체의 배열 및 수는 대조군과 유사한 소견으로 한방초콩환의 간조직 지방제거 효과를 기대할 수 있을 것으로 판단된다. The 1% dietary group (T1) of high fat and herbal soybean pill (T1) was able to observe the cytoplasm such as nucleus and mitochondria due to the abundance of fat globules compared to HF group, but the membranes of mitochondria and endoplasmic reticulum were unclear. Compared with T1, the 5% dietary herb (T5) group reduced the size and number of adipocytes and reduced the lipid content of the cytoplasm, resulting in a more pronounced form of organelles and a decrease in fat. And the number is similar to the control group can be expected to expect the liver tissue fat removal effect of herbal herbal soybean ring.
<그림 18> 전자현미경에 의한 <Figure 18> By electron microscope 간조직의Hepatic 지방세포 관찰 Fat cell observation
A : Normal, B : HF, C : T1, D : T5. Scale bar는 100 μm임. A: Normal, B: HF, C: T1, D: T5. Scale bar is 100 μm.
(nu : 핵, cy : 세포질, cm : 세포막, f : 지방세포) (nu: nucleus, cy: cytoplasm, cm: cell membrane, f: fat cell)
제3장 결론Chapter 3 Conclusion
제1절 Section 1 한방초콩환의Herbal soybean 개발에 적절한 한약재 Herbal Medicine Appropriate for Development
1. 한방초콩환의 제조를 위하여 8종의 한약재의 물과 에탄올 추출물로서 여러 가지 기능성 실험을 실시한 결과, 항산화능과 항암활성이 특히 우수한 5종류의 한약재(산조인, 백출, 산수유, 황기, 감초)가 초콩환에 첨가할 적절한 시료로 판단되었다. 1. Various functional experiments were conducted with water and ethanol extracts of eight kinds of Chinese herbal medicines for the preparation of Chinese herbal soybean pill. As a result, five kinds of Chinese herbal medicines (sanjoin, baekrye, cornus, sulfuric acid, licorice) have excellent antioxidative and anticancer activity. It was judged to be an appropriate sample to add to the soybean rings.
2. 3종류의 콩을 현미식초에 절이면서 절임기간에 따른 기호도 조사 결과, 3종류의 콩 모두 15일간 절인 콩의 기호도가 가장 높아서 15일간 절임이 적절한 것으로 생각되었다. 2. 3 types When pickling soybeans in brown rice vinegar and pickling period according to pickling period, the pickling of all three types of beans was the highest in 15 days.
3. 3종류의 콩을 15일간 식초에 절인 후, 식초콩의 Genistein 함량을 측정한 결과, 15일간 절인 콩이 Genistein 함량이 높았으며, 콩의 종류로는 서목태의 Genistein 함량이 가장 높아서 초콩환의 제조에 서목태가 가장 적합한 콩으로 판단되었다. 3. 3 types After soaking the soybeans in vinegar for 15 days and measuring the Genistein content of the vinegar, the soybeans pickled for 15 days had the highest content of Genistein, and the most varieties of soybeans had the highest content of Genistein in Seomoktae. Judging by the beans.
제2절 Section 2. 한방초콩환의Herbal soybean 적정 배합비율 및 효능 Proper Formulation Ratio and Efficacy
1. 초콩환에 첨가할 5종류의 한약재 첨가비율은 각각 2%가 적합한 농도로 판단되었다. 1. The ratio of 5 kinds of Chinese herbal medicines added to the soybean rings was 2%, respectively.
2. 5종류의 한약재 분말을 각각 2%씩 첨가하고, 15일간 절임 초콩분말을 난칼슘식초로서 반죽하여 제조한 최종제품(한방초콩환) 추출물은 우수한 항산화능, 항암작용을 나타내어 건강기능성 식품의 가치를 나타내는 것으로 판단되었다. 2. The final product (herbal vinegar soybean) extract prepared by adding 5% of herbal medicine powder 2% each and kneading pickled soybean powder as egg calcium vinegar for 15 days shows excellent antioxidant activity and anticancer activity. It was judged to represent value.
3. 최종제품의 효능 검증을 위하여 한방초콩환을 사료에 첨가하여 9주간 사육한 동물실험 결과, 고지방식이에 한방초콩환을 5% 첨가한 군(T-5)이 고지방식이군(HF)에 비해 체중, 내장지방, 간 무게 등이 감소하여 다이어트 효과를 가지는 것으로 판단되었다. 3. As a result of animal experiments of adding herbal herbal soybean pill to feed for 9 weeks to verify the efficacy of the final product, the group that added 5% herbal soybean pill to high fat diet (T-5) was the high fat diet group (HF). Compared with the weight loss, visceral fat, liver weight, etc., it was judged to have a diet effect.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070121462A KR100881089B1 (en) | 2007-11-27 | 2007-11-27 | The manufacturing method of herbal chokong (pickled soybean) pill |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070121462A KR100881089B1 (en) | 2007-11-27 | 2007-11-27 | The manufacturing method of herbal chokong (pickled soybean) pill |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100881089B1 true KR100881089B1 (en) | 2009-02-02 |
Family
ID=40680919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070121462A KR100881089B1 (en) | 2007-11-27 | 2007-11-27 | The manufacturing method of herbal chokong (pickled soybean) pill |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100881089B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180069397A (en) | 2016-12-15 | 2018-06-25 | 주식회사 유웰바이오 | Vinegared soybean with coffee vinegar and manufacturing method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990080149A (en) * | 1998-04-14 | 1999-11-05 | 윤명구 | Manufacturing method of vinegar bean processed product |
KR20050014614A (en) * | 2003-07-31 | 2005-02-07 | 손용만 | A beans as vinegar use of fermataion method and a beans paste of manufacturing process |
JP2005058177A (en) | 2003-08-20 | 2005-03-10 | Fujicco Co Ltd | Method for producing soybean pickles in vinegar and soybean pickles in vinegar obtained by the method and vessel-packaged soybean pickles in vinegar using the same |
KR20060052732A (en) * | 2006-04-06 | 2006-05-19 | 김숙희 | The manufaturing method of pill with black soybean and vinegar-egg shell-calcium containing black soybean and egg shell-calcium concentration |
-
2007
- 2007-11-27 KR KR1020070121462A patent/KR100881089B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990080149A (en) * | 1998-04-14 | 1999-11-05 | 윤명구 | Manufacturing method of vinegar bean processed product |
KR20050014614A (en) * | 2003-07-31 | 2005-02-07 | 손용만 | A beans as vinegar use of fermataion method and a beans paste of manufacturing process |
JP2005058177A (en) | 2003-08-20 | 2005-03-10 | Fujicco Co Ltd | Method for producing soybean pickles in vinegar and soybean pickles in vinegar obtained by the method and vessel-packaged soybean pickles in vinegar using the same |
KR20060052732A (en) * | 2006-04-06 | 2006-05-19 | 김숙희 | The manufaturing method of pill with black soybean and vinegar-egg shell-calcium containing black soybean and egg shell-calcium concentration |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180069397A (en) | 2016-12-15 | 2018-06-25 | 주식회사 유웰바이오 | Vinegared soybean with coffee vinegar and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102613652B (en) | Buckwheat beverage or tea bag and production method of buckwheat beverage or tea bag | |
KR20070111623A (en) | Pharmaceutical composition for treating or preventing diabetic complication containing an extract of chinese herb as an effective ingredient | |
KR101144920B1 (en) | An Extract with Red Ginseng and Herbs | |
CN107518260A (en) | A kind of food and preparation method thereof | |
KR101316091B1 (en) | Health assistance food using dendropanax morbifera and manufacturing method thereof | |
KR101060309B1 (en) | Restorative herb medicine with jujube and manufacturing method thereof | |
KR101621447B1 (en) | Pharmaceutical composition for anti-obesity comprising complex extracts including Saururi chinensis Baill. extract, Curcumae Longae Rhizoma extract and Polygalae Radix extract | |
EP1718167A1 (en) | Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof | |
KR20110125295A (en) | Health assistance food used the euphorbia humifusa wild by main raw material and the manufacturing method therof | |
KR20120070073A (en) | Rice wine using wax gourd and manufacturing method thereof | |
CN104824304A (en) | Selenium-enriched chocolate milk candy for old people | |
KR20080070182A (en) | A functional soy-bean source preventing hypertension and kidney trouble and process for preparation thereof | |
KR101083524B1 (en) | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup | |
KR100793205B1 (en) | Health Supporting Foods for Improving Coronary Heart Diseases or Arteriosclerosis Containing an Extract of Chinese Herb as an Effective Ingredient | |
KR100855665B1 (en) | Kochujang for anti-cholesterol comprising persimmon fruit and extracts of herb medicine mixture and a preparation method thereof | |
KR101061575B1 (en) | Drinks containing red ginseng and plant extracts | |
KR102149254B1 (en) | Pharnaceutical composition for prevention or treatment of diabetes comprising the mixed extract of vegetable natural products having the effect on removal of swelling and health functional food for prevention or improvement of diabetes comprising the same | |
KR100881089B1 (en) | The manufacturing method of herbal chokong (pickled soybean) pill | |
KR20190053108A (en) | A composition comprising the complex extract for antiobesity of men | |
KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
CN104893919A (en) | Preparation method of maize nourishing wine | |
KR101456127B1 (en) | A composition for increasing bone growth | |
KR101402600B1 (en) | Instant noodle manufacturing methods | |
KR100545407B1 (en) | Food composition for the treatment of the hyperlipidemia and its process | |
KR101018405B1 (en) | Compositions for the prevention and treatment of obesity comprising extracts of Vaccinium oldhami Miquel leaf as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121227 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140116 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150115 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151228 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170118 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190121 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20191224 Year of fee payment: 12 |